Germany· DE-A57-bc52cd1c22b42ba4
Anginetten
A medicinal product containing cetylpyridinium chloride monohydrate, registered in Germany by Divapharma Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Cetylpyridinium Chloride Monohydrate
- Manufacturer
- Divapharma Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cetylpyridinium chloride monohydrate in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAHLO PRO Healthy GumsGervest USA Inc
- CanadaANTISEPTIC ORAL RINSESAGE PRODUCTS LLC
- United KingdomAnbesol liquidAlliance Pharmaceuticals Ltd
- FranceNOVOPTINE 0,1 mg/0,4 ml, collyre en récipient unidoseSIFI (ITALIE)
- NorwayPyriseptKaro Pharma AS
- PolandHalsetBiofarm Sp. z o.o.
- CzechiaHALSETGebro Pharma GmbH, Fieberbrunn
- Japanセチルピリジニウム塩化物水和物岩城製薬
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Halset
- Czechia · Halset, Neoseptolete Třešeň
- France · Sedacollyre
- United Kingdom (Northern Ireland) · Antiseptic, First Aid Antiseptic
- Italy · Cetilsan, Cetilsan Senza Zucchero
- Malta · Cetilsan Sugar Free
- Norway · Pyrisept
- Poland · Halset, Septolete Junior
- Slovenia · Neoseptolete Z Okusom Divje Češnje, Neoseptolete Z Okusom Limone
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3b3d643b-e531-4140-91f1-c23235efa566 GET /v1/drugs/3b3d643b-e531-4140-91f1-c23235efa566?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oromucosal Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Cetylpyridinium Chloride Monohydrate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about cetylpyridinium chloride monohydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.